By Dennis Thompson HealthDay ReporterTUESDAY, June 24, 2025 (HealthDay News) — A new Chinese-developed GLP-1 weight loss drug could prove a new competitor to blockbuster drugs Ozempic /Wegovy and ...

A new potential drug treatment for people with type 2 diabetes and obesity lowers blood sugar and increases fat burning.

A high-throughput workflow for wide-targeted metabolomics in dried blood spots (DBS) is presented.

UCLA-led investigators say additional research is needed into why guideline-recommended genetic testing remains low among ...

Kelly Hindle has joined the board of Manchester digital agencies Fluid Commerce and Fluid Marketplaces as commercial director ...

The FDA has approved AstraZeneca and Daiichi Sankyo's Datroway (Datopotamab deruxtecan) for adults with NSCLC.

An article published in the journal Nature Metabolism presents an experimental drug that stimulates adipose tissue cells to ...

Cures Act expanded enrollment eligibility for Medicare Advantage to include people with end-stage kidney disease. Sometimes ...

In 2025, each issue of Population Health, Equity & Outcomes will feature a profile of a health system leader transforming ...

Kaviyoor Mahadevar Temple has a unique style of architecture and is one of the oldest temples in Kerala It is believed to have been constructed in the early years of the 10th century According to the ...